Anson Funds Management’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-14,263
Closed -$527K 28
2018
Q2
$527K Buy
+14,263
New +$527K 0.31% 13